The Lancet Breast Cancer Commission Review
| Authors: | Coles, C. E.; Earl, H.; Anderson, B. O.; Barrios, C. H.; Bienz, M.; Bliss, J. M.; Cameron, D. A.; Cardoso, F.; Cui, W.; Francis, P. A.; Jagsi, R.; Knaul, F. M.; McIntosh, S. A.; Phillips, K. A.; Radbruch, L.; Thompson, M. K.; AndreĢ, F.; Abraham, J. E.; Bhattacharya, I. S.; Franzoi, M. A.; Drewett, L.; Fulton, A.; Kazmi, F.; Inbah Rajah, D.; Mutebi, M.; Ng, D.; Ng, S.; Olopade, O. I.; Rosa, W. E.; Rubasingham, J.; Spence, D.; Stobart, H.; Vargas Enciso, V.; Vaz-Luis, I.; Villarreal-Garza, C.; on behalf of the Lancet Breast Cancer Commission |
| Review Title: | The Lancet Breast Cancer Commission |
| Keywords: | review; cancer recurrence; doxorubicin; cancer growth; cancer risk; cancer radiotherapy; cancer incidence; quality of life; breast cancer; mastectomy; breast neoplasms; cancer therapy; risk factor; cancer mortality; exemestane; health care policy; cost effectiveness analysis; health care cost; breast tumor; tamoxifen; physical activity; terminal care; lifestyle modification; anastrozole; awareness; genetic screening; medical service; health care access; health education; raloxifene; humans; human; female; middle income country; lancet breast cancer commission |
| Journal Title: | Lancet |
| Volume: | 403 |
| Issue: | 10439 |
| ISSN: | 0140-6736 |
| Publisher: | Elsevier Science, Inc. |
| Date Published: | 2024-05-11 |
| Start Page: | 1895 |
| End Page: | 1950 |
| Language: | English |
| DOI: | 10.1016/s0140-6736(24)00747-5 |
| PUBMED: | 38636533 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Review -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
